Back to search

Netherlands· NL-cbf884064d25

Mirapexin 1,57 mg, tabletten met verlengde afgifte

A pramipexole product containing pramipexoldihydrochloride 1-water, registered in Netherlands by Boehringer Ingelheim International GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC N04BC05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMirapexin 1,57 mg, tabletten met verl…ATCN04BC05REGISTER NO.NL-cbf884064d25PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Pramipexole is registered in 18 of 19 countries.

Countries holding a registration under ATC N04BC05 (pramipexole), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Pramipexole · ATC N04BC05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pramipexole costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.28 in United States to $5.68 in Switzerland — a ×20 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Pramipexole · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.68
  • IT Italy$2.62
  • FR France$1.32
  • US United States$0.28 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PRAMIPEXOLDIHYDROCHLORIDE 1-WATER
Manufacturer
Boehringer Ingelheim International GmbH
Country
Netherlands (NL)
ATC code
N04BC05
ATC class
Pramipexole
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/97/051

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

197 interactions on record for pramipexole.

Graded by severity as the source publishes them — 51 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pramipexole · interactions on record

197 records

  • 51 moderate
  • 3 minor
  • 138 info

Most severe, free to view

  • CimetidineA02BA01moderate
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pramipexole in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pramipexole products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Calmolan, Calmolan Retard
  • Belgium · Pramipexol, Pramipexol Eg
  • Bulgaria · Parson, Peximyr 0,18 Mg
  • Cyprus · Medopexol, Rapexole
  • Czechia · Calmolan, Glepark
  • Germany · Glepark, Pexapral
  • Denmark · Glepark, Mariprax
  • Spain · Pramipexol Aurovitas, Pramipexol Aurovitas Spain
  • Finland · Pramipexol, Pramipexol Stada
  • France · Pramipexole Arrow Lab, Pramipexole Biogaran
  • United Kingdom (Northern Ireland) · Pipexus, Pramipexole Glenmark Pharmaceuticals Europe
  • Greece · Glepark, Mariprax
  • Croatia · Pramipeksol Pliva
  • Hungary · Calmolan, Erimexol
  • Ireland · Miramel
  • Iceland · Mirapexin, Oprymea
  • Italy · Pramiperal, Pramipexolo Aurobindo
  • Liechtenstein · Mirapexin, Pramipexole Teva
  • Lithuania · Pramipexole Orion
  • Luxembourg · Pramipexol Eg, Pramipexole Eg
  • Latvia · Pramipexole Elvim, Pramipexole Orion
  • Malta · Pramipexole Aurobindo
  • Norway · Mirapexin, Oprymea
  • Portugal · Pramipexol Aurobindo, Pramipexol Azevedos
  • Romania · Pramipexol Arena, Pramipexol Stada
  • Sweden · Calmolan, Derinik
  • Slovakia · Glepark, Pramipexol Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9c4241c8-687f-4e4d-b5cb-9ecfa1a344a3
GET /v1/drugs/9c4241c8-687f-4e4d-b5cb-9ecfa1a344a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mirapexin-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Pramipexole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp106473",
  "excipients": [
    "CARBOMEER 941",
    "HYPROMELLOSE 2208 (Release controlling polymer), K15M (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "PRAMIPEXOLDIHYDROCHLORIDE 1-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2010/06/10",
  "procedure_number": "EMEA/H/C/000134",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/97/051",
  "additional_monitoring": "N"
}

See everything about pramipexole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.